• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非痛风性关节沉积病的治疗:最新进展

Treatment of nongout joint deposition diseases: an update.

作者信息

Pascart Tristan, Richette Pascal, Flipo René-Marc

机构信息

Department of Rheumatology, Saint-Philibert Hospital, Service de Rhumatologie, Lille Catholic University, rue du Grand But, 59160 Lomme, France ; Department of Rheumatology, Roger Salengro Hospital, Lille 2 University, rue Emile Laine, 59037 Lille Cedex, France.

Federation of Rheumatology, Lariboisiere Hospital, Assistance Publique-Hopitaux de Paris, UFR Medicale, Paris 7 University, 75475 Paris Cedex 10, France.

出版信息

Arthritis. 2014;2014:375202. doi: 10.1155/2014/375202. Epub 2014 May 8.

DOI:10.1155/2014/375202
PMID:24895535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4034491/
Abstract

This update develops the actual therapeutic options in the management of the joint involvement of calcium pyrophosphate deposition disease (CPPD), basic calcium phosphate (BCP) deposition disease, hemochromatosis (HH), ochronosis, oxalosis, and Wilson's disease. Conventional pharmaceutical treatment provides benefits for most diseases. Anti-interleukine-1 (IL-1) treatment could provide similar results in CPPD than in gout flares. There is only limited evidence about the efficacy of preventive long-term colchicine intake, methotrexate, and hydroxychloroquine in chronic CPPD. Needle aspiration and lavage have satisfactory short and midterm results in BCP. Extracorporeal shockwave therapy has also proved its efficacy for high-doses regimes. Phlebotomy does not seem to have shown real efficacy on joint involvement in HH so far. Iron chelators' effects have not been assessed on joint involvement either, while IL-1 blockade may prove useful. NSAIDs have limited efficacy on joint involvement of oxalosis, while colchicine and steroids have not been assessed either. The use of nitisinone for ochronotic arthropathy is still much debated, but it could provide beneficial effects on joint involvement. The effects of copper chelators have not been assessed either in the joint involvement of Wilson's disease. NSAIDs should be avoided because of the liver affection they may worsen.

摘要

本次更新阐述了焦磷酸钙沉积病(CPPD)、碱性磷酸钙(BCP)沉积病、血色素沉着症(HH)、褐黄病、草酸盐沉积症和威尔逊氏病关节受累的实际治疗选择。传统药物治疗对大多数疾病都有疗效。抗白细胞介素-1(IL-1)治疗在CPPD中可能产生与痛风发作时相似的效果。关于预防性长期服用秋水仙碱、甲氨蝶呤和羟氯喹在慢性CPPD中的疗效,仅有有限的证据。针吸和灌洗在BCP中具有令人满意的短期和中期效果。体外冲击波疗法在高剂量方案中也已证明其疗效。放血疗法迄今似乎并未显示出对HH关节受累有实际疗效。铁螯合剂对关节受累的影响也未得到评估,而IL-1阻断可能证明是有用的。非甾体抗炎药(NSAIDs)对草酸盐沉积症关节受累的疗效有限,秋水仙碱和类固醇也未得到评估。对于褐黄病性关节病使用尼替西农仍存在很多争议,但它可能对关节受累产生有益影响。铜螯合剂对威尔逊氏病关节受累的影响也未得到评估。由于可能会加重肝脏损害,应避免使用NSAIDs。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/4034491/231da8b8810a/ARTHRITIS2014-375202.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/4034491/b55e02da0f91/ARTHRITIS2014-375202.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/4034491/adada45dd187/ARTHRITIS2014-375202.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/4034491/231da8b8810a/ARTHRITIS2014-375202.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/4034491/b55e02da0f91/ARTHRITIS2014-375202.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/4034491/adada45dd187/ARTHRITIS2014-375202.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06c/4034491/231da8b8810a/ARTHRITIS2014-375202.003.jpg

相似文献

1
Treatment of nongout joint deposition diseases: an update.非痛风性关节沉积病的治疗:最新进展
Arthritis. 2014;2014:375202. doi: 10.1155/2014/375202. Epub 2014 May 8.
2
Recent advances in the therapeutic management of calcium pyrophosphate deposition disease.焦磷酸钙沉积病治疗管理的最新进展
Front Med (Lausanne). 2024 Mar 11;11:1327715. doi: 10.3389/fmed.2024.1327715. eCollection 2024.
3
Update on calcium pyrophosphate deposition.焦磷酸钙沉积病的最新进展
Clin Exp Rheumatol. 2016 Jul-Aug;34(4 Suppl 98):32-8. Epub 2016 Jul 22.
4
Idiopathic calcium pyrophosphate dihydrate (CPPD) crystal deposition disease in a young male patient: a case report.一名年轻男性患者的特发性焦磷酸钙二水合物(CPPD)晶体沉积病:病例报告
J Korean Med Sci. 2003 Dec;18(6):917-20. doi: 10.3346/jkms.2003.18.6.917.
5
Calcium Pyrophosphate Dihydrate Deposition Disease in Young Patients: Two Case Reports.年轻患者的二水焦磷酸钙沉积病:两例报告
Arch Rheumatol. 2016 Dec 8;32(1):80-83. doi: 10.5606/ArchRheumatol.2017.6015. eCollection 2017 Mar.
6
Calcium pyrophosphate dihydrate (CPPD) deposition in ochronotic arthropathy.焦磷酸钙二水合物(CPPD)在褐黄病性关节病中的沉积
J Clin Pathol. 1983 Aug;36(8):894-902. doi: 10.1136/jcp.36.8.894.
7
[Calcium pyrophosphate dihydrate crystal induced arthropathy].[二水焦磷酸钙晶体诱导的关节病]
Rev Med Suisse. 2007 Mar 21;3(103):740-2, 744, 746.
8
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.甲氨蝶呤治疗慢性复发性焦磷酸钙沉积病:一项随机交叉试验显示无显著疗效
Arthritis Res Ther. 2014 Oct 15;16(5):458. doi: 10.1186/s13075-014-0458-4.
9
Therapy for CPPD: Options and Evidence.CPPD 治疗:选择和证据。
Curr Rheumatol Rep. 2018 Apr 19;20(6):31. doi: 10.1007/s11926-018-0739-z.
10
[Update on Gout and Calcium pyrophosphate deposition (CPPD)].[痛风与焦磷酸钙沉积症(CPPD)的最新进展]
Dtsch Med Wochenschr. 2018 Aug;143(16):1157-1166. doi: 10.1055/a-0504-5684. Epub 2018 Aug 7.

引用本文的文献

1
The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.全身铁稳态机制以及遗传性血色素沉着症的病因、诊断和治疗
Int J Hematol. 2018 Jan;107(1):31-43. doi: 10.1007/s12185-017-2365-3. Epub 2017 Nov 13.
2
Hemochromatosis: a model of metal-related human toxicosis.血色病:一种与金属相关的人类中毒模型。
Environ Sci Pollut Res Int. 2018 Jan;25(3):2007-2013. doi: 10.1007/s11356-016-7576-2. Epub 2016 Sep 15.
3
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.

本文引用的文献

1
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases.阿那白滞素治疗痛风性关节炎的疗效:40 例回顾性研究。
Arthritis Res Ther. 2013;15(5):R123. doi: 10.1186/ar4303.
2
Calcium pyrophosphate deposition disease of the temporomandibular joint.颞下颌关节焦磷酸钙沉积病
J Neurol Surg Rep. 2012 Oct;73(1):6-8. doi: 10.1055/s-0032-1329190.
3
A systematic review of shockwave therapies in soft tissue conditions: focusing on the evidence.冲击波疗法治疗软组织疾病的系统评价:关注证据。
药物研发中的氯喹类似物:从疟疾到多种疾病的新应用方向、作用机制及毒性表现
J Antimicrob Chemother. 2015;70(6):1608-21. doi: 10.1093/jac/dkv018. Epub 2015 Feb 17.
Br J Sports Med. 2014 Nov;48(21):1538-42. doi: 10.1136/bjsports-2012-091961. Epub 2013 Aug 5.
4
ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients.促肾上腺皮质激素作为14例住院患者急性焦磷酸钙晶体关节炎的一线治疗药物。
Joint Bone Spine. 2014 Jan;81(1):98-100. doi: 10.1016/j.jbspin.2013.05.006. Epub 2013 Jun 25.
5
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.抗氧化剂可抑制人尿黑酸症细胞模型中 SAA 的形成和促炎细胞因子的释放。
Rheumatology (Oxford). 2013 Sep;52(9):1667-73. doi: 10.1093/rheumatology/ket185. Epub 2013 May 23.
6
Calcific tendinitis of the rotator cuff: a randomized controlled trial of ultrasound-guided needling and lavage versus subacromial corticosteroids.肩袖钙化性肌腱炎:超声引导下针刺灌洗与肩峰下皮质类固醇注射的随机对照研究。
Am J Sports Med. 2013 Jul;41(7):1665-73. doi: 10.1177/0363546513487066. Epub 2013 May 21.
7
A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?接受地拉罗司治疗的多个类别患者的死亡人数创历史新高:监管和营销程序中的漏洞危及患者安全并误导公共资金?
Expert Opin Drug Saf. 2013 Sep;12(5):605-9. doi: 10.1517/14740338.2013.799664. Epub 2013 May 21.
8
Update on oxalate crystal disease.草酸盐晶体病的最新进展。
Curr Rheumatol Rep. 2013 Jul;15(7):340. doi: 10.1007/s11926-013-0340-4.
9
Short-term efficacy of hyaluronic acid joint injections in a case of ochronotic arthropathy.
J Clin Rheumatol. 2013 Apr;19(3):152-3. doi: 10.1097/RHU.0b013e318289e7fa.
10
Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.黑尿酸症小鼠模型中的褐黄病性骨关节病,以及尼替西农对此的抑制作用。
Ann Rheum Dis. 2014 Jan;73(1):284-9. doi: 10.1136/annrheumdis-2012-202878. Epub 2013 Mar 19.